SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041688
Filing Date
2021-08-05
Accepted
2021-08-05 16:56:05
Documents
70
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arvn-10q_20210630.htm   iXBRL 10-Q 1777078
2 EX-10.1 arvn-ex101_99.htm EX-10.1 572206
3 EX-31.1 arvn-ex311_9.htm EX-31.1 21049
4 EX-31.2 arvn-ex312_6.htm EX-31.2 21048
5 EX-32.1 arvn-ex321_7.htm EX-32.1 9486
6 EX-32.2 arvn-ex322_8.htm EX-32.2 9408
  Complete submission text file 0001564590-21-041688.txt   7256081

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA arvn-20210630.xsd EX-101.SCH 49492
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arvn-20210630_cal.xml EX-101.CAL 44076
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arvn-20210630_def.xml EX-101.DEF 172475
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20210630_lab.xml EX-101.LAB 392082
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20210630_pre.xml EX-101.PRE 299383
12 EXTRACTED XBRL INSTANCE DOCUMENT arvn-10q_20210630_htm.xml XML 1112785
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38672 | Film No.: 211149200
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences